The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens

Haematologica. 2008 Sep;93(9):1420-2. doi: 10.3324/haematol.12846. Epub 2008 Jul 18.

Authors

Meletios Athanasios Dimopoulos, Efstathios Kastritis, Sossana Delimpassi, Athanasios Zomas, Marie Christine Kyrtsonis, Konstantinos Zervas

PMID: 18641029
DOI: 10.3324/haematol.12846

No abstract available

Publication types

Letter

MeSH terms

Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents / immunology*
Antineoplastic Agents / therapeutic use*
Female
Humans
Immunotherapy
Male
Prognosis
Rituximab
Societies, Medical
Survival Rate
Waldenstrom Macroglobulinemia / drug therapy*
Waldenstrom Macroglobulinemia / immunology
Waldenstrom Macroglobulinemia / pathology*

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Rituximab